多囊卵巢综合征子宫内膜来源上皮类器官作为研究子宫内膜功能障碍的新模型
研究首次从多囊卵巢综合征(PCOS)女性子宫内膜样本建立上皮类器官(EEO),并与BMI匹配的对照比较。PCOS来源EEO炎症相关基因表达增加、直径减小,超重/肥胖PCOS组对雌二醇和孕酮反应异常、容受性相关基因表达降低;双氢睾酮(DHT)未影响转录组。作者认为该模型可捕捉PCOS子宫内膜异常。
要点
- 首次成功建立PCOS来源子宫内膜上皮类器官,可捕捉炎症增加和容受性基因表达降低。
- 超重/肥胖PCOS来源EEO对雌二醇和孕酮反应异常,容受性相关基因PAEP和LIF表达降低。
- 培养中加入DHT未影响EEO转录组,与EEO中雄激素受体表达极低一致。
核心结论
- 首次建立PCOS来源EEO,可捕捉PCOS子宫内膜异常,包括炎症增加和容受性相关基因表达降低。
研究设计与样本
- 从两个队列女性子宫内膜活检建立EEO:超重/肥胖PCOS(O-PCOS,n=4)和瘦型PCOS(L-PCOS,n=4),以及BMI匹配对照(超重/肥胖对照O-Ctrl,n=4;瘦型对照L-Ctrl,n=4)。
- EEO暴露于β-雌二醇(E2)、孕酮、cAMP和Wnt/β-catenin信号(WNT)抑制剂XAV-939组合6天以模拟增殖期或分泌期,同期有或无双氢睾酮(DHT)暴露。
- 采用bulk RNA测序识别PCOS与对照EEO间基因表达差异,RT-qPCR验证;HE染色和免疫染色评估形态;激素暴露6天后评估EEO大小。
主要发现
- 两个BMI组的PCOS EEO均显示炎症相关基因表达增加(包括OSMR和ICAM1表达增加),且直径较各自对照EEO减小。
- O-PCOS EEO对E2和孕酮暴露显示异常反应(包括容受性相关基因PAEP和LIF表达降低),与对照EEO相比。
- 培养中加入DHT未影响EEO转录组,与EEO中雄激素受体(AR)表达极低一致。
局限性
- 研究应以更大样本量和其他PCOS表型(除不同体重类别外)重复。
- 作为首个建立PCOS EEO的工作,未来研究应聚焦于在共培养系统中纳入其他子宫内膜细胞类型,包括免疫细胞。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: Are we able to establish endometrium epithelial organoids (EEOs) from endometrial samples obtained from women with PCOS, and do they differ from non-PCOS EEOs? SUMMARY ANSWER: We were able to establish, for the first time, PCOS EEOs which capture endometrial abnormalities present in women with PCOS, including increased inflammation and decreased receptivity-related gene expression. WHAT IS KNOWN ALREADY: Patient-derived EEOs could serve as a tool to study endometrial dysfunction, as diseased tissue-derived organoid models typically retain the disease-related traits. In PCOS, endometrial dysfunction likely contributes to subfertility and pregnancy complications, yet previous research on the endometrial epithelial compartment has been scarce and, so far, no PCOS-derived EEOs have been established. STUDY DESIGN, SIZE, DURATION: EEOs were established from endometrial biopsies from two cohorts of women with PCOS-including overweight/obese (O-PCOS, n = 4) and lean (L-PCOS, n = 4)-along with BMI-matched controls (overweight/obese control (O-Ctrl), n = 4; lean control (L-Ctrl), n = 4). EEOs were exposed to combinations of steroid hormones (β-estradiol (E2), progesterone, cAMP, and the Wnt/β-catenin signaling (WNT) inhibitor XAV-939) for 6 days to simulate the proliferative or secretory phases of the menstrual cycle, with or without simultaneous androgen exposure with dihydrotestosterone (DHT). PARTICIPANTS/MATERIALS, SETTING, METHODS: Bulk RNA-sequencing was conducted to identify variations in gene expression between PCOS and Ctrl EEOs, while reverse-transcription quantitative PCR RT-qPCR was employed to validate these results. Morphological assessment of EEOs was performed using hematoxylin and eosin staining and immunostaining. The size of EEOs was evaluated after 6 days of hormonal exposure. MAIN RESULTS AND THE ROLE OF CHANCE: PCOS EEOs from both BMI groups demonstrated increased inflammation-related gene expression (including increased expression of Oncostatin M Receptor (OSMR) and Intercellular Adhesion Molecule 1 (ICAM1)) and showed a reduced diameter compared to their respective control EEOs. The O-PCOS EEOs displayed an aberrant response to steroid exposure with E2 and progesterone (including reduced expression of receptivity-related genes progestagen-associated endometrial protein and leukemia inhibitory factor) as compared to control EEOs. Addition of DHT to the culture media did not affect EEO transcriptome, aligning with the minimal androgen receptor (AR) expression in the EEOs. LARGE SCALE DATA: Sequencing data are available from the corresponding author upon request. LIMITATIONS, REASONS FOR CAUTION: The study should be replicated with a larger number of samples and with other PCOS phenotypes apart from different weight categories. Furthermore, as this work is the first one to establish PCOS EEOs, future studies should focus on incorporating other endometrial cell types, including immune cells, in a co-culture system. WIDER IMPLICATIONS OF THE FINDINGS: This novel in vitro organoid model for PCOS captures the endometrial abnormalities present in the two weight categories of women with PCOS, thereby providing a valuable tool to gain insights into PCOS-related endometrial dysfunction. Our findings propose potential links to the increased risk of pregnancy complications in women with PCOS, such as the role of altered receptivity and implantation environment including increased inflammation, which may contribute to aberrant placentation and subsequent placental dysfunction. STUDY FUNDING/COMPETING INTEREST(S): Jusélius Foundation, Novo Nordisk Foundation, Research Council of Finland, Horizon 2020 Marie-Curie MATER Innovative Training Network (all to T.T.P.), Fund for Scientific Research Flanders-Belgium (FWO, G0A6719N to J.V. and GO99023N to H.V.); KU Leuven Research Fund (C14/21/116 to H.V. and C14/24/152 to J.V.), University of Oulu Scholarship Foundation Grant (to L.L.), and PhD grant of China Scholarship Council (CSC, to M.W.). The authors have no conflicts of interest to declare.
引用
- Luyckx L, Wei M, Saarela U, et al. PCOS endometrium-derived epithelial organoids as a novel model to study endometrial dysfunction. Hum Reprod. 2025. PMID: 40499150. doi:10.1093/humrep/deaf113
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。